AMGEN INC — Director's Dealing 2021

Sep 14, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2021-09-13

Reporting Person: Khosla Rachna (SVP, Business Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4068	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Nqso (Right to Buy)	$162.60	2027-05-01	Common Stock (1252)		Direct
Nqso (Right to Buy)	$177.46	2028-04-27	Common Stock (1518)		Direct
Nqso (Right to Buy)	$177.31	2029-05-03	Common Stock (3642)		Direct
Nqso (Right to Buy)	$236.36	2030-05-05	Common Stock (2515)		Direct
Nqso (Right to Buy)	$239.64	2031-04-30	Common Stock (3260)		Direct

Footnotes

F1: These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Equity Incentive Plan: 67 RSUs which will vest on 4/27/2022; 554 RSUs which will vest on 7/31/2022; 280 RSUs which vest in installments of 138 on 5/3/2022 and 142 on 5/3/2023; 300 RSUs which vest in two installments of 99 on 5/5/2022 and 5/5/2023 and one installment of 102 on 5/5/2024; and 375 RSUs which vest in installments of 123 on 4/30/2023, 124 on 4/30/2024 and 128 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These shares include 90 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F3: 1,252 of these non-qualified stock options have vested and are exercisable.

F4: 1,001 of these non-qualified stock options have vested and are exercisable and 517 of these options will vest and become exercisable on 4/27/2022.

F5: 1,201 of these non-qualified stock options have vested and are exercisable and the remaining options will vest and become exercisable in installments of 1,202 on 5/3/2022 and 1,239 on 5/3/2023.

F6: These non-qualified stock options will vest and become exercisable in three installments of 829 on 5/5/2022, 830 on 5/5/2023 and 856 on 5/5/2024.

F7: These non-qualified stock options will vest and become exercisable in three installments of 1,075 on 4/30/2023, 1,076 on 4/30/2024 and 1,109 on 4/30/2025.